EUVIMEDEUVIMED entdecken
Multizentrische Studie

Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis

Clayton J Brinster, Samuel R Money, Aaron Hayson, René Gurdian, Ross Milner, Kayla Polcari, Mark Asirwatham, Dean J Arnaoutakis, Chong Li, Thomas Maldonado, Dillon Cheung, Andrew Meltzer

Journal of Vascular Surgery · 2024

DOI: 10.1016/j.jvs.2023.09.017 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Vascular Surgery, 2024. Verfasst von Clayton J Brinster und 11 weiteren Autor:innen. Beteiligte Einrichtung: Vascular Surgery Section, Ochsner Health, New Orleans, LA. Electronic address: clayton.brinster@ochsner.org. Hauptthemen laut MEDLINE: Blood Vessel Prosthesis Implantation, Aortic Aneurysm, Abdominal, Endovascular Procedures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Complex endovascular juxta-, para- and suprarenal abdominal aortic aneurysm repair (comEVAR) is frequently accomplished with commercially available fenestrated (FEVAR) devices or off-label use of aortoiliac devices with parallel branch stents (chEVAR). We sought to evaluate the implantable vascular device costs incurred with these procedures as compared with standard Medicare reimbursement to determine the financial viability of comEVAR in the modern era. METHODS: Five geographically distinct institutions with high-volume, complex aortic centers were included. Implantable aortoiliac and branch stent device cost data from 25 consecutive, recent, comEVAR in the treatment of juxta-, para-, and suprarenal aortic aneurysms at each center were analyzed. Cases of rupture, thoracic aneurysms, reinterventions, and physician-modified EVAR were excluded, as were ancillary costs from nonimplantable equipment. Data from all institutions were combined and stratified into an overall cost group and two, individual cost groups: FEVAR or chEVAR. These groups were compared, and each respective group was then compared with weighted Medicare reimbursement for Diagnosis-Related Group codes 268/269. Median device costs were obtained from an independent purchasing consortium of >3000 medical centers, yielding true median cost-to-institution data rather than speculative, administrative projections or estimates. RESULTS: A total of 125 cases were analyzed: 70 FEVAR and 53 chEVAR. Two cases of combined FEVAR/chEVAR were included in total cost analysis, but excluded from direct FEVAR vs chEVAR comparison. Median Medicare reimbursement was calculated as $35,755 per case. Combined average implantable device cost for all analyzed cases was $28,470 per case, or 80% of the median reimbursement ($28,470/$35,755). Average FEVAR device cost per case ($26,499) was significantly lower than average chEVAR cost per case ($32,122; P < .002). Device cost was 74% ($26,499/$35,755) of total reimbursement for FEVAR and 90% ($32,122/$35,755) for chEVAR. CONCLUSIONS: Results from this multi-institutional analysis show that implantable device cost alone represents the vast majority of weighted total Medicare reimbursement per case with comEVAR, and that chEVAR is significantly more costly than FEVAR. Inadequate Medicare reimbursement for these cases puts high-volume, high-complexity aortic centers at a distinct financial disadvantage. In the interest of optimizing patient care, these data suggest a reconsideration of previously established, outdated, Diagnosis-Related Group coding and Medicare reimbursement for comEVAR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood Vessel Prosthesis ImplantationAortic Aneurysm, AbdominalEndovascular ProceduresAgedHumansUnited StatesEndovascular Aneurysm RepairBlood Vessel ProsthesisRisk FactorsTreatment OutcomeMedicareStentsHospital CostsRetrospective StudiesProsthesis Design

Stichwörter der Autor:innen

Cost analysisEVARFEVARMedicareReimbursementchEVAR

Autor:innen und Institutionen

  • Vascular Surgery Section, Ochsner Health, New Orleans, LA. Electronic address: clayton.brinster@ochsner.org.
  • Vascular Surgery Section, Ochsner Health, New Orleans, LA.
  • Section of Vascular Surgery and Endovascular Therapy, University of Chicago Health Center, Chicago, IL.
  • Division of Vascular Surgery, University of South Florida Health, Tampa, FL.
  • NYU Langone Vascular and Endovascular Surgery Associates, NYU Langone Health, New York, NY.
  • Vascular and Endovascular Surgery, Mayo Clinic Scottsdale, Scottsdale, AZ.

Zitieren

APA

Brinster, C. J., Money, S. R., Hayson, A., Gurdian, R., Milner, R., Polcari, K., Asirwatham, M., Arnaoutakis, D. J., Li, C., Maldonado, T., Cheung, D., & Meltzer, A. (2024). Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2023.09.017

Vancouver

Brinster CJ, Money SR, Hayson A, Gurdian R, Milner R, Polcari K, et al. Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis. Journal of Vascular Surgery. 2024. doi:10.1016/j.jvs.2023.09.017

BibTeX
@article{Brinster2024,
  author = {Brinster, Clayton J and Money, Samuel R and Hayson, Aaron and Gurdian, René and Milner, Ross and Polcari, Kayla and Asirwatham, Mark and Arnaoutakis, Dean J and Li, Chong and Maldonado, Thomas and Cheung, Dillon and Meltzer, Andrew},
  title = {Current Medicare reimbursement for complex endovascular aortic repair is inadequate based on results from a multi-institutional cost analysis},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  doi = {10.1016/j.jvs.2023.09.017}
}
Kostenlos starten →